The DOI matches its Crossref record.
Endothelial Dysfunction in Human Disease
Abstract
The vascular endothelium plays a key role in the local regulation of vascular tone by the release of vasodilator substances (i.e. endothelium-derived relaxing factor (EDRF = nitric oxide, NO) and prostacyclin) and vasoconstrictor substances (i.e. thromboxane A2, free radicals, or endothelin). Using either agents like acetylcholine or changes in flow to stimulate the release of EDRF (NO), clinical studies have revealed the importance of EDRF in both basal and stimulated control of vascular tone in large epicardial coronary arteries and in the coronary microcirculation. The regulatory function of the endothelium is altered by cardiovascular risk factors or disorders such as hypercholesterolemia, chronic smoking, hypertension or chronic heart failure. Endothelial dysfunction appears to have detrimental functional consequences as well as adverse longterm effects, including vascular remodelling. Endothelial dysfunction is associated with impaired tissue perfusion particularly during stress and paradoxical vasoconstriction of large conduit vessels including the coronary arteries. These effects may cause or contribute to myocardial ischemia. Several mechanisms may be involved in the development of endothelial dysfunction, such as reduced synthesis and release of EDRF or enhanced inactivation of EDRF after its release from endothelial cells by radicals or oxidized low-density lipoprotein (LDL). Increased plasma levels of oxidized LDL have been noted in chronic smokers and are related to the extent endothelial dysfunction, raising the possibility that chronic smoking potentiates endothelial dysfunction by increasing circulating and tissue levels of oxidized LDL. In heart failure, cytokines and/or reduced flow (reflecting reduced shear stress) may be involved in the development of endothelial dysfunction and can be reversed by physical training. Other mechanisms include an activated renin-angiotensin system (i.e. postmyocardial infarction) with increased breakdown of bradykinin by enhanced angiotensin converting enzyme (ACE) activity. There is evidence that endogenous bradykinin is involved in coronary vasomotor control both in coronary conduit and resistance vessels. ACE inhibitors enhance endothelial function by a bradykinin-dependent mechanism and probably also by blunting the generation of superoxide anion. Endothelial dysfunction appears to be reversible by administering L-arginine, the precursor of nitric oxide, lowering cholesterol levels, physical training, antioxidants such as vitamin C, or ACE inhibition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A few studies have found inhibitory effects of dietary nitrate on platelet aggregation, suggesting that inhibition of abnormal platelet aggregation may be partly responsible for the cardiovascular benefits of nitrate supplementation.”
From The effects of dietary nitrate on blood pressure and endothelial function: a review of human intervention studies (2013) · cites this paper as [106]
In the citing paper
“For example, Richardson et al. (106) demonstrated that a single 2 mmol bolus of potassium nitrate inhibited platelet aggregation by up to 31 % in healthy individuals.”
From The effects of dietary nitrate on blood pressure and endothelial function: a review of human intervention studies (2013) · cites this paper as [106]
Citations
Cited by
Sorted by citations
Items 301–400 of 473
Arg–Gly–Asp (RGD)-containing peptides increase soluble guanylate cyclase in contractile cells
Díez-Marqués, M. L., Ruiz‐Torres, M. P., Griera, M., et al. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.10.011 · Cited by 13
“Cardiovascular disorders are characterized by impaired vasodilatory responses after acetylcholine administration [1–3].”
BackgroundIs It Possible to Train the Endothelium?—A Narrative Literature Review
Biernat, K., Kuciel, N., Mazurek, J., & Hap, K. (2024) · Life · doi:10.3390/life14050616 · Cited by 12
Mulligan, A. A., Lentjes, M. A. H., Skinner, J. S., & Welch, A. A. (2024) · Antioxidants · doi:10.3390/antiox13080962 · Cited by 13
“Dysfunction of the endothelium, induced by inflammation, has been associated with CVD and hypertension [81] and has also been linked to the development of insulin resistance and type 2 diabetes [82,83].”
BackgroundChi, J., Hong, X., Wang, Y., et al. (2013) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3182a56297 · Cited by 12
“Endothelial injury and dysfunction contribute to the development of atherosclerosis, and the equilibrium between endothelial injury and regeneration is of particular importance in cardiovascular disease.(10) Risk factors predisposing to atherosclerosis are associated with endothelial dysfunction.”
Poitras, V. J., Slattery, D. J., Levac, B. M., et al. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2013.077131 · Cited by 12
“This is of critical importance because there is growing agreement that endothelial dysfunction precedes and plays a role in the development of atherosclerosis (Celermajer et al. 1992; Drexler & Hornig, 1999; Kawashima & Yokoyama, 2004).”
BackgroundTobacco-associated pulmonary vascular dysfunction in smokers: role of the ET-1 pathway
Henno, P., Boitiaux, J. F., Douvry, B., Cazes, A., Lévy, M., Devillier, P., Delclaux, C., & Israël‐Biet, D. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00251.2010 · Cited by 12
“In our experimental conditions, endothelial dysfunction was defined as a lack of relaxation or even a contraction response (16).”
Ohanyan, V. A., Sisakian, H. S., Peketi, P., et al. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00154.2018 · Cited by 12
Role of iNOS in Insulin Resistance and Endothelial Dysfunction
Aggarwal, H., Kanuri, B., & Dikshit, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_21 · Cited by 11
L ‐Arginine inhibits xanthine oxidase‐dependent endothelial dysfunction in hypercholesterolemia
White, C. R., Parks, D. A., Patel, R. P., Shelton, J. E., Tarpey, M. M., Freeman, B. Α., & Darley-Usmar, V. M. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00137-1 · Cited by 12
Li, X., Wang, L., Li, Y., Ho, Y., Yang, D., Chen, Y., Hu, X., & Xue, M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.027 · Cited by 12
Manipulating Glutathione-S-Transferases May Prevent the Development of Tolerance to Nitroglycerin
Wang, L., Yang, Y., Dwivedi, S., Xu, Y. F., Chu, E. T., Li, J., Fitchett, K., & Boor, P. J. (2006) · Cardiovascular Toxicology · doi:10.1385/ct:6:2:131 · Cited by 12
“including type 2 diabetes, smoking and ischemic heart disease (25) are associated with endothelial dysfunction and derangements in vasomotion due to alterations in endothelial NO metabolism.”
BackgroundAngiotensin II overproduction: enemy of the vessel wall
Ferrari, R. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90070-2 · Cited by 11
“The endothelium plays a crucial role in the maintenance of normal vascular tone and structure, local homeostasis and vascular wall proliferation processes[9].”
BackgroundNutritional phenolics and cardiovascular disease
Virgili, F., Scaccini, C., Packer, L., et al. (2003) · Elsevier eBooks · doi:10.1533/9781855736986.1.5 · Cited by 12
Chan, H., Lougheed, M., Laher, I., et al. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200306000-00005 · Cited by 12
“The mechanism of action of antioxidants in the prophylaxis or treatment of atherosclerosis is generally thought to be to prevent LDL oxidation and thereby eliminate its harmful consequences.(40) However, in vivo studies suggest that antioxidants may also have a direct effect on preserving endothelial function.”
BackgroundDover, A. R., Chia, S., Ferguson, J., et al. (2006) · Clinical Science · doi:10.1042/cs20060104 · Cited by 12
“Heart failure is a chronic inflammatory state [4] associated with endothelial dysfunction [5,6], and more specifically, impairment of nitric oxide mediated endotheliumdependent vasodilatation [7-11].”
BackgroundEFFECT OF ECE AND NEP INHIBITION ON CIGARETTE SMOKE-INDUCED CELL PROLIFERATION IN THE RAT LUNG
Wright, A. Y. J. J. L. (2001) · Inhalation Toxicology · doi:10.1080/08958370117619 · Cited by 12
The Protective Role of Vitamin C on Endothelial Dysfunction
Korantzopoulos, P. G., & Galaris, D. (2003) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 12
Selected markers of endothelial dysfunction in women with polycystic ovary syndrome.
Fołtyn, W., Strzelczyk, J., Marek, B., et al. (2011) · PubMed · Cited by 11
Mollnau, H., Oelze, M. W., Zinßius, E., Hausding, M., Wu, Z., Knorr, M., Kerahrodi, J. G., Kröller‐Schön, S., Jansen, T., Teutsch, C., et al. (2013) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-013-0842-7 · Cited by 11
Sartório, C. L., Pinto, V. D., Cutini, G. J. S., Vassallo, D. V., & Stefanon, I. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000156822.58081.be · Cited by 11
Arterial Wall-Determined Risk Factors to Vascular Diseases: A Nonhuman Primate Model
Wang, X. L., Wang, J., Shi, Q. S., et al. (2004) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:40:3:371 · Cited by 11
“The eNOS isoform is mainly found in vascular endothelium and is responsible for continuous release of NO to regulate vascular tone (9,41,43).”
BackgroundGranulomatous Variant of Pigmented Purpuric Dermatosis
Tato, B. P., Escobedo, S. M., González, Y. C. P., et al. (2012) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e31823f616a · Cited by 11
“In the microcirculation, these manifestations are known to be more evident in postcapillary venules.(9,10) We can postulate that hyperlipidemia may have promoted the granulomatous inflammatory reaction of skin microvasculature, induced by microdeposits due to hypercholesterolemia, similar to the proposed mechanism of…”
Endothelial [Ca2+]i is an integrating signal for the vascular tone in rat aortae
Huang, T., Chen, H., Liu, C.-Y., et al. (2001) · BMC Physiology · doi:10.1186/1472-6793-1-5 · Cited by 11
“Background Vascular endothelium plays an important role in controlling vascular tone by secreting a variety of endotheliumderived relaxing factors (endothelial autacoids), namely NO, prostacyclin (PGI2), and L-NNA/indomethacin-insensitive relaxing factor [1,2,3].”
BackgroundAdvances in Lipid-Lowering Therapy in Atherosclerosis
Davignon, J. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1321-6_8 · Cited by 12
Hyperhomocysteinemia and cardiovascular disease: The nutritional perspectives
Pandey, R., Gupta, S., Lal, H., et al. (2000) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02867541 · Cited by 11
Dietary habit of smokers in a Chinese population
J. Woo, S. C. H. (2001) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637480020027000-6-3 · Cited by 11
Gupta, S. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.10.013 · Cited by 11
“Various In vitro endothelial cells Increased NO bioavailability [43]”
BackgroundBauersachs, J. K., Fraccarollo, D., Schäfer, A., & Ertl, G. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200210000-00013 · Cited by 11
Changes in vascular identity during vascular remodeling
Aoyagi, Y., Schwartz, A. W., Li, Z., Bai, H., Gonzalez, L. A., Lazcano-Etchebarne, C., Ohashi, Y., Kano, M., Ho, B., Martin, K. A., et al. (2025) · JVS Vascular Science · doi:10.1016/j.jvssci.2025.100282 · Cited by 11
DPP-4 inhibitors and atherosclerosis: The promise
Jialal, I., & Bajaj, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.12.033 · Cited by 10
Kumari, N., Yadav, A., Ahirwar, R., et al. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201117 · Cited by 10
Primary culture of microvascular endothelial cells from human benign prostatic hyperplasia
Stachon, A., Schlüter, T., Köller, M., et al. (2001) · The Prostate · doi:10.1002/pros.1094 · Cited by 10
Upper extremity exercise testing and training.
Blomqvist, C. G. (1985) · PubMed · Cited by 10
Shpagina, L. A., Gerasimenko, O. N., Novikova, I. I., et al. (2022) · Russian Journal of Occupational Health and Industrial Ecology · doi:10.31089/1026-9428-2022-62-3-146-158 · Cited by 9
Digiacomo, M., Martelli, A., Testai, L., et al. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.12.043 · Cited by 9
“In particular, the NO-NAT derivative 4, selected as the lead compound in this experimental work, was endowed of satisfactory hypoglycaemic effects, comparable to those exhibited by the “parent drug” NAT.”
BackgroundMethodInfluentialIron in kidney and heart failure: from theory to practice
Yerlikaya, A., Bulbul, M. C., Afşar, B., Dağel, T., Aslan, G., Voroneanu, L. E., Siriopol, D., Covic, A. C., & Kanbay, M. (2017) · International Urology and Nephrology · doi:10.1007/s11255-017-1708-6 · Cited by 9
Chen, S., Chu, C., Jiang, C., et al. (2019) · Journal of Food and Nutrition Research · doi:10.12691/jfnr-7-5-3 · Cited by 9
“The vasoactive substances, including nitric oxide (NO), prostacyclin (PGI2) and endotheliumderived hyperpolarizing factor derived from endothelium, play an important role in ameliorating hypertension [4].”
BackgroundHemodynamics and cerebrovascular disease
Tateshima, S., Tanishita, K., & Viñuela, F. (2008) · Surgical Neurology · doi:10.1016/j.surneu.2008.07.010 · Cited by 9
Spontaneous spasm of the arterial duct: a pitfall for transcatheter occlusion
Tzifa, A. (2004) · Heart · doi:10.1136/hrt.2004.035147 · Cited by 9
Cicco, S., Solimando, A. G., Buono, R., et al. (2020) · Life · doi:10.3390/life10100247 · Cited by 9
“In fact, due to the increase in RV pre-load, the increase in shear stress will induce endothelial damage [48,49].”
BackgroundThorin, É. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200102000-00010 · Cited by 9
Disminución de la reserva de flujo coronario en pacientes con insuficiencia cardíaca no isquémica
Coma-Canella, I., García‐Velloso, M. J., Macı́as, A., et al. (2003) · Revista Española de Cardiología · doi:10.1016/s0300-8932(03)76878-x · Cited by 9
Baron‐Menguy, C., Toutain, B., Cousin, M., et al. (2010) · Hypertension Research · doi:10.1038/hr.2010.83 · Cited by 9
Effect of inhibition of nitric oxide synthase on the vasopressor response to ephedrine
Dabisch, P. A., Liles, J. T., & Kadowitz, P. J. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-100 · Cited by 9
“Endothelial dysfunction is characterized by loss of endothelium-dependent vasodilation and is thought to be a common pathway for cardiovascular events such as vasospasm, hypertension, and myocardial infarction (Drexler and Hornig 1999; LopezJaramillo and Casas 2002).”
BackgroundKrassói, I., Pataricza, J., & Papp, J. G. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702667 · Cited by 8
“There is evidence that endogenous bradykinin is involved in the vasomotor control of conduit-type coronary arteries and appears to have cardioprotective actions (Drexler & Hornig 1999; Blais et al 2000).”
BackgroundVascular Remodeling in Health and Disease
Melo, L. G., Gnecchi, M., Ward, C. A., & Dzau, V. J. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_74 · Cited by 11
“However, risk factors for cardiovascular disease induce oxidative stress, which plays a major role in endothelial dysfunction.(6,7) Reactive oxygen species accelerate the catabolism of NO and activate redox-sensitive transcription factors such as NF-κB, which upregulate the transcription of various proinflammatory gen…”
BackgroundCardiovascular Regulation: Basic Considerations
Mancia, G., Lüscher, T. F., Shepherd, J. T., Noll, G., & Grassi, G. M. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_73 · Cited by 8
Stachon, A., Schlüter, T., Junker, K., et al. (2004) · Growth Factors · doi:10.1080/08977190400004835 · Cited by 8
“ATP is known to be a strong regulator of the vascular tone, mediating this effect in part by the activation of endothelial cells (Furchgott and Vanhoutte, 1989; Stachon et al., 1998; Drexler and Hornig, 1999; Mombouli and Vanhoutte, 1999).”
BackgroundYekeler, E., Dursun, M., Emeksiz, E., et al. (2007) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2007.2523 · Cited by 8
Soysal, D., Savaş, S., Susam, İ., et al. (2003) · PubMed · Cited by 8
Mayer, B., & Hemmens, B. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0984 · Cited by 8
Angiotensin Receptor Blockers: Novel Role in High-Risk Patients
Javed, U., & DEEDWANIA, P. C. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.07.001 · Cited by 7
Gökkaya, C. S., Aktaş, B. K., Toprak, U., Yahşi, S., Bulut, S., Özden, C., & Memiş, A. (2011) · International Journal of Impotence Research · doi:10.1038/ijir.2011.46 · Cited by 7
Cheung, Y. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-11851-7.00006-9 · Cited by 10
Jeon, S. Y., Kim, M. R., Yu, S. H., Kim, M. J., Shim, K.-S., Shin, E., Lee, J. J., & Lee, Y. C. (2020) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2020.25.2.173 · Cited by 8
“Decreased levels of endothelium-derived NO are associated with pathophysiological modifications that occur in several vascular diseases (Drexler and Hornig, 1999).”
BackgroundReview: Interaction among angiotensin II, nitric oxide and oxidative stress
Zhou, M.-S., Adam, A., & Raij, L. R. (2001) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203010020011001 · Cited by 7
Drakos, S. G., Papamichael, C. M., Alexopoulos, G. P., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00029-8 · Cited by 7
From tissue wasting to cachexia: changes inperipheral blood flow and skeletal musculature
Sharma, R. K., & Anker, S. D. (2002) · European Heart Journal · doi:10.1016/s0195-668x(02)80023-9 · Cited by 7
“Endothelial dysfunction can result in impaired tissue perfusion (particularly during stress) and myocardial ischaemia, and may also have adverse long-term effects on vascular remodelling[8].”
BackgroundManagement of valvular heart disease during pregnancy.
Anandaraja, S., Ss, K., & Vk, B. (2005) · PubMed · Cited by 7
Wazir, N. U., Khan, I. A., Javed, A., Khan, T., & Jabbar, A. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103712 · Cited by 6
“The normal functions of the endothelium are impaired in hyperlipidemia and hypertension (Drexler and Hornig, 1999; Felmeden et al., 2003) as a result of shear and oxidative stresses.”
BackgroundIntracellular peptides in SARS-CoV-2-infected patients
Martucci, L. F., Eichler, R. A. D. S., da Silva, R. D. N. O., Costa, T. J. D., Tostes, R. C., Busatto, G. F., Seelaender, M. C. L., Duarte, A. J. S., de Souza, H. P., & Ferro, E. S. (2023) · iScience · doi:10.1016/j.isci.2023.107542 · Cited by 5
Contribution and Regulation of Calcium Channels in Endothelial Cells
Cheng, K. T., Rosenhouse‐Dantsker, A., & Malik, A. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-29635-7_2 · Cited by 6
“Vascular tone Bradykinin (16), acetylcholine (73), Tg (77) AEA, EET , GSK, Tg (75, 76, 77) ATP, Bradykinin (72) ATP, Adenosine, Epinephrine, Thromboxane A2 (78-80)”
Chikopela, T., Goma, F. M., Kaluba, L., Mutale, W., Guure, C. B., Heimburger, D. C., & Koethe, J. R. (2021) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v22i1.1298 · Cited by 6
Li, L., Huang, X., Jia, Z., Wu, Y., & Zheng, Q. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.04.001 · Cited by 6
Synergistic effects of C-peptide and insulin on coronary flow in early diabetic rats
Nakamoto, H., Sakane, N., Kimura, K., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.014 · Cited by 6
Vayssettes‐Courchay, C., Ragonnet, C., Camenen, G., et al. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.02.018 · Cited by 6
“In metabolic and cardiovascular diseases, including hypertension, atherosclerosis and diabetes, this balance shifts towardvasoconstriction and is accompanied by endothelium disruption, platelet and leucocyte–vascular wall interaction, increased oxidative stress and endothelial dysfunction (Drexler and Horning, 1999; P…”
BackgroundInfluentialHu, T., She, Q., Jiang, Y., Su, L., & Yin, Y. (2008) · AGE · doi:10.1007/s11357-008-9074-z · Cited by 6
“…and anti-adhesion moieties, and increase production of vasoconstrictor, proadhesion, and prothrombotic molecules, leading to elevated vascular tone, enhanced cell adhesion, proliferation of media smooth muscle cells, and propensity toward thrombosis (Drexler and Hornig 1999; Rubanyi 1993).”
BackgroundXu, J., Su, L., Chen, L., et al. (2014) · Genetics and Molecular Research · doi:10.4238/2014.september.5.9 · Cited by 6
“…the secretion of vascular relaxation substances, such as NO, and significantly increases the abundance of vasoconstrictor substances, such as endothelin (ET) (Hedner and Sun, 1997); next, the self-regulation system based on the ET/NO balance in vivo becomes damaged (Drexler and Hornig, 1999).”
BackgroundSilent Partner in Blood Vessel Homeostasis? Pervasive Role of Nitric Oxide in Vascular Disease
Deeb, R. S., Lamon, B. D., & Hajjar, D. P. (2009) · Current Hypertension Reviews · doi:10.2174/157340209789587726 · Cited by 6
Influence of haemodialysis on early markers of atherosclerosis
Kovačić, V., Ljutić, D., Dodig, J., et al. (2008) · Nephrology · doi:10.1111/j.1440-1797.2008.00945.x · Cited by 6
“ED is a central concept in current models of the pathogenesis of atherothrombotic disease.(18) Determination of ED also has important clinical implications.”
Experimental vascular graft for liver transplantation
Kob́ori, L., Németh, T., Nemes, B., et al. (2003) · Acta Veterinaria Hungarica · doi:10.1556/avet.51.2003.4.11 · Cited by 6
“The donor endothelial cells are different and present dysfunction in numerous pathological conditions like atherosclerosis, transplantation or cytomegalovirus infection (Ev-ans et al., 1999; Drexler and Hornig, 1999).”
Graf, C., & Halle, M. (2015) · Der Kardiologe · doi:10.1007/s12181-014-0568-x · Cited by 5
Nitric oxide therapy For cardiovascular disease
Laight, D. W. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.6.999 · Cited by 5
“Indeed, NO is now recognised as a principal pleiotropic mediator of cardiovascular homeostasis, a deficiency which is linked with the development of atherosclerosis, vasospasm, thrombosis, restenosis, essential hypertension and erectile dysfunction [6-8].”
BackgroundHarrison, B. D. (2003) · Thorax · doi:10.1136/thorax.58.7.555 · Cited by 5
Mechanisms of Cellular Alterations Due to Ischemia-Reperfusion Injury in the Heart
Temsah, R. M., Netticadan, T., & Dhalla, N. S. (2003) · Progress in experimental cardiology · doi:10.1007/978-1-4615-0355-2_11 · Cited by 5
LDL oxidation and LDL particle size in the development of atherosclerosis
Liu, M. (2002) · Työväentutkimus Vuosikirja · Cited by 5
Zhou, J., Lim, S. H., & Chiu, J. (2011) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-011-0199-2 · Cited by 4
Khaki‐Khatibi, F., Samadi, N., & Yaghoubi, A. (2016) · Journal of Analytical Research in Clinical Medicine · doi:10.15171/jarcm.2016.031 · Cited by 4
RetractedMatsubara, K., Matsubara, Y., & Ito, M. (2009) · Vascular Disease Prevention · doi:10.2174/1567270000906010163 · Cited by 6
Kob́ori, L., Németh, T., Nagy, P., et al. (2008) · Acta Veterinaria Hungarica · doi:10.1556/avet.56.2008.3.14 · Cited by 4
“The donor endothelial cells are different and present dysfunction in numerous pathological conditions such as atherosclerosis, transplantation or cytomegalovirus infection (Evans et al., 1999; Drexler and Hornig, 1999).”
BackgroundMatsubara, K., Matsubara, Y., & Ito, M. (2009) · Vascular Disease Prevention · doi:10.2174/1567270001006010163 · Cited by 4
Cardiovascular disease and nutritional phenolics
Virgili, F., Scaccini, C., Packer, L., et al. (2010) · Woodhead Publishing Limited eBooks · doi:10.1533/9781855736160.2.87 · Cited by 4
Wang, Y., & Xiaorong, B. (2015) · European journal of medical research · doi:10.1186/s40001-015-0124-6 · Cited by 4
RetractedWu, Y., Bouws, P., Lorenzen, S., et al. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1681-9_11 · Cited by 3
Dyson, K. S., Argarwal, N., Williams-Bell, M., et al. (2011) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2011.01036.x · Cited by 3
“Endothelial dysfunction is associated with the major risk factors for atherosclerosis and has been shown to be observed early in the course of atherogenesis, even before structural lesions can be found (Anderson, 1997; Drexler & Hornig, 1999; Verma et al., 2003).”
BackgroundPositive influence of aspirin on coronary endothelial function: Importance of the dose
Teragawa, H. (2013) · World Journal of Cardiology · doi:10.4330/wjc.v5.i11.426 · Cited by 3
Aging and the Cerebral Microvasculature
Sorond, F. A., & Lipsitz, L. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-378638-8.00016-6 · Cited by 3
Endothelium‐targeted Gene and Cell‐based Therapy for Cardiovascular Disease
Melo, L. G., Pachori, A. S., Kong, D., Gnecchi, M., & Dzau, V. J. (2007) · doi:10.1002/9780470988473.ch26 · Cited by 3
Wensvoort, G. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110964 · Cited by 2
Stammzelltherapie nach akutem Myokardinfarkt
Brehm, M., Darrelmann, E., & Strauer, B. E. (2008) · Der Internist · doi:10.1007/s00108-008-2079-y · Cited by 2
Review on Hypothetical Implementing TGF-β Family Members in Glaucoma Therapy.
Šoša, I., Čulina, K., & Bosnar, A. (2012) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 2
Efeitos da sauna sobre doenças cardiovasculares e doenças relacionadas com o estilo de vida
Talebipour, B., Rodrigues, L. O. C., & Moreira, M. C. V. (2006) · Revista Brasileira de Medicina do Esporte · doi:10.1590/s1517-86922006000400010 · Cited by 2
Kabiri, N. (2011) · African Journal of Pharmacy and Pharmacology · doi:10.5897/ajpp11.476 · Cited by 2
“Statins help nitric oxide synthesis and improve endothelial function (Drexler and Horning, 1999) and (Koh et al., 2000), and inhibit the production of inflammatory cytokines and chemokines, improve autonomic function, and quash myocardial remodeling (Hayashidani et al., 2002); Lefer, 2002).”
BackgroundJung, C. S., Oldfield, E. H., Harvey-White, J. D., et al. (2007) · Journal of neurosurgery · doi:10.3171/jns.2007.107.5.945 · Cited by 2
The Association of Passive Smoking and Serum Urotensin-II Levels in Children
Bozkurt, H. B., Yayla, M., Binnetoğlu, D., & Evran, M. (2022) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202220201488 · Cited by 2
Subchronic stress effects on vascular reactivity in C57BL/6 strain mice
Ramírez-Rosas, E., Velázquez, P. N., Verdugo‐Díaz, L., Pérez-Armendáriz, E. M., Juárez-Oropeza, M. A., & Paredes-Carbajal, M. C. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.03.007 · Cited by 2
Kolář, F., Ošťádalová, I., Ošťádal, B., et al. (2003) · Progress in experimental cardiology · doi:10.1007/978-1-4615-0347-7_6 · Cited by 2
Buikema, H. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000163136.51717.8f · Cited by 2
(2004) · Postgraduate Medical Journal · doi:10.1136/pgmj.2004.019356corr1 · Cited by 2
From tissue wasting to cachexia: changes in peripheral blood flow and skeletal musculature
SHARMA, R., & Anker, S. D. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90155-0 · Cited by 2
“Endothelial dysfunction can result in impaired tissue perfusion (particularly during stress) and myocardial ischaemia, and may also have adverse long-term effects on vascular remodelling[8].”
Background
Metadata
- Authors
- Drexler, H., & Hornig, B.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Venue
- Journal of Molecular and Cellular Cardiology
- Publisher
- Elsevier BV
- Published
- 1999-01
- Volume
- 31
- Issue
- 1
- Pages
- 51-60
- ISSN
- 0022-2828 (ISSN-L)
- OpenAlex
- W2074957886
- Cited by
- 471
- References
- 0
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 4 · 2020: 7 · 2019: 11 · 2018: 4 · 2017: 7 · 2016: 14 · 2015: 11 · 2014: 18 · 2013: 23 · 2012: 19
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Molecular and Cellular Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- endothelial dysfunction, nitric oxide, endothelium-derived relaxing factor, coronary microcirculation, oxidized LDL, chronic smoking, heart failure, renin-angiotensin system, bradykinin, ACE inhibitors, L-arginine, exercise training, antioxidants, myocardial ischemia, vascular remodeling, shear stress, hypertension, hypercholesterolemia
- MeSH terms
- Acetylcholine, Ascorbic Acid, Cardiac Output, Low, Coronary Disease, Dose-Response Relationship, Drug, Endothelium, Vascular, Enzyme Inhibitors, Humans, Hypercholesterolemia, Hyperemia, Lipoproteins, LDL, Radial Artery, omega-N-Methylarginine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review